SCHEMBL15480779

SCHEMBL15480779

O=CNc1cccc(C(=O)NC2CCCCCCCC23COC3)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.41
KDM4E B2RXH2 5/20 0.36
LMNA P02545 5/20 0.36
HPGD P15428 4/20 0.36
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HTT P42858 1/20 0.36
BCL2 P10415 2/20 0.35
BID P55957 1/20 0.35
BCL2L1 Q07817 1/20 0.35
MCL1 Q07820 1/20 0.35
BCL2L2 Q92843 1/20 0.35
BCL2L10 Q9HD36 1/20 0.35
CYP3A4 P08684 4/20 0.34
MEN1 O00255 3/20 0.34
MAPK1 P28482 3/20 0.34
KMT2A Q03164 3/20 0.34
HSD17B10 Q99714 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15480780 0.81 ALDH1A1 (0.44) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL15534635 0.79 ALDH1A1 (0.57) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL15480774 0.79 ALDH1A1 (0.57) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL15480784 0.79 ALDH1A1 (0.57) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL15476462 0.79 ALDH1A1 (0.57) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL8515079 0.79 ALDH1A1 (0.57) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL15535350 0.79 ALDH1A1 (0.57) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL8514055 0.73 TAS1R3 (0.44) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL15480782 0.73 TAS1R3 (0.44) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL8514066 0.73 TAS1R3 (0.44) KDM4ELMNAHPGDALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051678-A1 INHIBITORS OF THE ACTIVITY OF COMPLEX III OF THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN AND USE THEREOF FOR TREATING DISEASES STEMERGIE BIOTECHNOLOGY SA (CH) 2014-02-20 US disclosed
US-20140051678-A1 INHIBITORS OF THE ACTIVITY OF COMPLEX III OF THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN AND USE THEREOF FOR TREATING DISEASES STEMERGIE BIOTECHNOLOGY SA (CH) 2014-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051678-A1 INHIBITORS OF THE ACTIVITY OF COMPLEX III OF THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN AND USE THEREOF FOR TREATING DISEASES SQOR, MT-ND3, MT-CO3 CCR6 4844/4885KDM4E 3660/4885LMNA 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.